Enhanced analytical sensitivity of a quantitative PCR for CMV using a modified nucleic-acid extraction procedure

Area of Science:

• Medical diagnostics
• Molecular biology
• Virology

Background:

• Accurate diagnosis of Cytomegalovirus (CMV) disease in immunocompromised individuals is challenging.
• Quantitative PCR (QPCR) in peripheral blood mononuclear cells (PBMC) improves diagnostic accuracy, but plasma detection has lower negative predictive value.
• Enhancing QPCR sensitivity for plasma specimens is critical for timely CMV disease management.

Purpose of the Study:

• To improve the sensitivity of QPCR assays for detecting CMV DNA in plasma specimens.
• To optimize nucleic acid extraction from plasma to minimize inhibitors and enhance CMV detection.
• To evaluate the impact of plasma centrifugation and reduced DNA resuspension volume on QPCR assay performance.

Main Methods:

• Plasma samples were centrifuged before nucleic acid extraction, with optimization to reduce inhibitors.
• Extracted DNA was resolubilized in a reduced volume to enhance QPCR sensitivity.
• Quantitation involved co-amplifying an internal quantitative standard (IS) with CMV-specific primers.
• PCR products were detected using hybridization on a 96-well microtiter plate with specific probes.

Main Results:

• Centrifugation of plasma before nucleic acid extraction and reduced DNA resuspension volume enhanced analytical sensitivity approximately tenfold.
• The dynamic range of linearity for pelleted plasma was 20 to 40,000 viral copies/ml, compared to 300 to 400,000 vc/ml for untreated plasma.
• The precision (coefficient of variation) of the QPCR assay was similar for both untreated and pelleted plasma samples, especially when data were log-transformed.

Conclusions:

• Centrifugation of plasma prior to nucleic acid extraction significantly enhances the sensitivity of QPCR for CMV DNA detection.
• This optimized method offers a tenfold increase in analytical sensitivity over the assay's dynamic range.
• The improved sensitivity is crucial for accurate and timely diagnosis of CMV disease in immunocompromised patients.